Logo image of AIDX.CA

HEALWELL AI INC (AIDX.CA) Stock Fundamental Analysis

TSX:AIDX - Toronto Stock Exchange - CA42249X1006 - Common Stock - Currency: CAD

1.54  -0.1 (-6.1%)

Fundamental Rating

2

Taking everything into account, AIDX scores 2 out of 10 in our fundamental rating. AIDX was compared to 17 industry peers in the Health Care Providers & Services industry. AIDX has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AIDX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AIDX had negative earnings in the past year.
AIDX had a negative operating cash flow in the past year.
AIDX had negative earnings in each of the past 5 years.
In multiple years AIDX reported negative operating cash flow during the last 5 years.
AIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFAIDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M

1.2 Ratios

AIDX's Return On Assets of -39.37% is on the low side compared to the rest of the industry. AIDX is outperformed by 68.75% of its industry peers.
AIDX has a worse Return On Equity (-70.05%) than 68.75% of its industry peers.
Industry RankSector Rank
ROA -39.37%
ROE -70.05%
ROIC N/A
ROA(3y)-43.6%
ROA(5y)-27.19%
ROE(3y)-161.57%
ROE(5y)-285.34%
ROIC(3y)N/A
ROIC(5y)N/A
AIDX.CA Yearly ROA, ROE, ROICAIDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600 -800

1.3 Margins

AIDX's Gross Margin of 41.54% is fine compared to the rest of the industry. AIDX outperforms 68.75% of its industry peers.
AIDX's Gross Margin has declined in the last couple of years.
AIDX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.96%
GM growth 5Y-12.54%
AIDX.CA Yearly Profit, Operating, Gross MarginsAIDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

AIDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AIDX has more shares outstanding
AIDX has more shares outstanding than it did 5 years ago.
AIDX has a worse debt/assets ratio than last year.
AIDX.CA Yearly Shares OutstandingAIDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
AIDX.CA Yearly Total Debt VS Total AssetsAIDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.01, we must say that AIDX is in the distress zone and has some risk of bankruptcy.
AIDX has a Altman-Z score (1.01) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.17 indicates that AIDX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.17, AIDX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACCN/A
WACC7.51%
AIDX.CA Yearly LT Debt VS Equity VS FCFAIDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

AIDX has a Current Ratio of 0.97. This is a bad value and indicates that AIDX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.97, AIDX is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 0.97 indicates that AIDX may have some problems paying its short term obligations.
AIDX's Quick ratio of 0.97 is in line compared to the rest of the industry. AIDX outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
AIDX.CA Yearly Current Assets VS Current LiabilitesAIDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AIDX have decreased strongly by -30.55% in the last year.
AIDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 56.75%.
AIDX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.48% yearly.
EPS 1Y (TTM)-30.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.57%
Revenue 1Y (TTM)56.75%
Revenue growth 3Y-42.54%
Revenue growth 5Y-30.48%
Sales Q2Q%399.64%

3.2 Future

Based on estimates for the next years, AIDX will show a very strong growth in Earnings Per Share. The EPS will grow by 28.56% on average per year.
The Revenue is expected to grow by 12.98% on average over the next years. This is quite good.
EPS Next Y-112.5%
EPS Next 2Y18.59%
EPS Next 3Y28.56%
EPS Next 5YN/A
Revenue Next Year-34.66%
Revenue Next 2Y57.46%
Revenue Next 3Y48.29%
Revenue Next 5Y12.98%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AIDX.CA Yearly Revenue VS EstimatesAIDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
AIDX.CA Yearly EPS VS EstimatesAIDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AIDX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIDX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIDX.CA Price Earnings VS Forward Price EarningsAIDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIDX.CA Per share dataAIDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

AIDX's earnings are expected to grow with 28.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.59%
EPS Next 3Y28.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIDX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALWELL AI INC

TSX:AIDX (2/21/2025, 7:00:00 PM)

1.54

-0.1 (-6.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-26 2025-03-26/amc
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners3.77%
Ins Owner ChangeN/A
Market Cap260.00M
Analysts83.08
Price Target4.22 (174.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)64.06%
Min EPS beat(2)-30.72%
Max EPS beat(2)158.83%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.63%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)3.32%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.48%
PT rev (3m)12.54%
EPS NQ rev (1m)10%
EPS NQ rev (3m)-80%
EPS NY rev (1m)1.92%
EPS NY rev (3m)-4.94%
Revenue NQ rev (1m)-3.27%
Revenue NQ rev (3m)135.96%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-9.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.29
P/FCF N/A
P/OCF N/A
P/B 3.61
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.21
BVpS0.43
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.37%
ROE -70.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.54%
FCFM N/A
ROA(3y)-43.6%
ROA(5y)-27.19%
ROE(3y)-161.57%
ROE(5y)-285.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.96%
GM growth 5Y-12.54%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.02%
Cap/Sales 5.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 1.01
F-Score5
WACC7.51%
ROIC/WACCN/A
Cap/Depr(3y)26.39%
Cap/Depr(5y)18.16%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.57%
EPS Next Y-112.5%
EPS Next 2Y18.59%
EPS Next 3Y28.56%
EPS Next 5YN/A
Revenue 1Y (TTM)56.75%
Revenue growth 3Y-42.54%
Revenue growth 5Y-30.48%
Sales Q2Q%399.64%
Revenue Next Year-34.66%
Revenue Next 2Y57.46%
Revenue Next 3Y48.29%
Revenue Next 5Y12.98%
EBIT growth 1Y-143.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-62.19%
EBIT Next 3Y23.99%
EBIT Next 5Y22.98%
FCF growth 1Y-149.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-184.89%
OCF growth 3YN/A
OCF growth 5YN/A